[Effects of corticosteroid treatment repeated at short intervals on tryptophan-nicotinic acid pathway in man].
D000293:Adolescent; D000328:Adult; D000618:Aminohippuric Acids / Q000652:urine*; D001623:Betamethasone / Q000494:pharmacology* / Q000627:therapeutic use; D003404:Creatinine / Q000652:urine*; D005260:Female; D006801:Humans; D007736:Kynurenic Acid / Q000652:urine*; D009539:Nicotinic Acids / Q000378:metabolism* / Q000652:urine; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D012216:Rheumatic Diseases / Q000188:drug therapy; D013997:Time Factors; D014364:Tryptophan / Q000378:metabolism*; D014977:Xanthurenates / Q000652:urine*
D000618:Aminohippuric Acids; D009539:Nicotinic Acids; D011506:Proteins; D014977:Xanthurenates; D012313:RNA; D014364:Tryptophan; D001623:Betamethasone; D003404:Creatinine; D007736:Kynurenic Acid
Effetto di replicazione ravvicinata di un trattamento cortisonico sulla linea triptofano leads to acido nicotinico nell'uomo.